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Recent advances in DNA sequencing technology are trans-
forming our understanding of the genetic basis of rare
human diseases. It is now possible to rapidly and cost-
effectively interrogate the majority of protein-coding bases
in the human genome (known collectively as the exome),
finding mutations that would have been difficult if not
impossible to discover with the traditional approaches of
linkage and candidate gene sequencing.
However, unambiguously identifying the disease-causing
mutations in a patient’s exome remains challenging.
Next-generation sequencing, while powerful, still requires
careful filtering to remove errors and is underpowered for
discovery of larger insertions/deletions (indels) and com-
plex variants; coverage of genes is incomplete due to biases
in DNA capture and sequencing; and predicting the likely
functional impact of observed variants is still an immature
science. Importantly, existing catalogues both of “normal”
variation in reference populations and of reported disease-
causing mutations are incomplete and biased. Finally,
methods for communicating the results of large-scale
sequencing to key target audiences - clinicians, patients and
researchers from other fields - remain poorly developed.
In this presentation I describe recent advances in var-
iant-calling from next-generation sequencing technology,
and their application to exome data from over 15,000 indi-
viduals from multiple different disease-specific studies.
Functional annotation of sequence variants across these
large samples illustrates the surprising degree of putatively
functional genetic variation even in apparently healthy
individuals. However, the existence of a very large and
accurately called reference panel of exomes provides a
powerful resource for interpreting the probability of
disease causation for variants observed in rare disease
samples. I also discuss new approaches to analyzing
and presenting the results from family-based studies of
protein-coding mutations in rare disease patients.
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